ADVOCATE. CONNECT. INNOVATE.

Category Archives: Bulletin

California Life Sciences Association Invites You To the 2018 S.T.E.M. Olympics

California Life Sciences Association Invites You To the 2018 S.T.E.M. Olympics Matching Intelligence with Good Times for A Great Cause La Jolla, California – February 2, 2018 –   Bright minds with big hearts and a flare for fun are invited to compete in the First Annual S.T.E.M. Olympics, slated for Wednesday evening, May 2, 5:30 … Continue reading California Life Sciences Association Invites You To the 2018 S.T.E.M. Olympics

Introducing the Spring 2018 FAST Companies

Six life science startups, vetted and selected by a distinguished review panel, have been selected for CLSI’s Spring 2018 Fellows All-Star Team (FAST) Advisory Program. The Spring 2018 FAST companies are: Abalone Bio, developing functional antibody therapeutics that block or activate membrane protein using proprietary Functional Antibody Selection Technology platform; Antibiotic Adjuvant, developing AI-empowered decision … Continue reading Introducing the Spring 2018 FAST Companies

President’s Corner – New Year, New Look for CLSA Bulletin; CLSA Commends Suspension of Medical Device Tax; CLSA Honors Life Sciences Champions at Back to Session Reception; and Upcoming Events

By: Sara Radcliffe CLSA President & CEO January 31, 2018    New Year, New Look CLSA anticipates an action-packed 2018, and we’re kicking it off with a fresh new look for our Bulletin.  Below you will see key information in the President’s Corner and the Spotlight, followed closely by New Member announcements. Our current legislative and … Continue reading President’s Corner – New Year, New Look for CLSA Bulletin; CLSA Commends Suspension of Medical Device Tax; CLSA Honors Life Sciences Champions at Back to Session Reception; and Upcoming Events

Protocols.io Offers Free Access to Private Groups to CLSA Members

Protocols.io is a web and mobile platform for organizing, sharing, and keeping research methods up-to-date. It enables R&D teams to keep their protocols safe in one single place and to collaborate on method development and protocol optimization, within their private groups. Your CLSA membership gives you access to all the benefits and resources of private … Continue reading Protocols.io Offers Free Access to Private Groups to CLSA Members

NEW COURSE on UNDERSTANDING DRUG PRICING

CLSI is offering a new professional development seminar on February 28 aimed at helping participants understand the complex decisions that guide drug pricing decisions. Taught by Biotech Primer, “Understanding Drug Pricing” will provide invaluable information to those in government, finance, law, insurance and human resources who are seeking to gain a better grasp on how … Continue reading NEW COURSE on UNDERSTANDING DRUG PRICING

Guest Article: UC Santa Cruz MCD Biology launches Curricular Undergraduate Research Experiences (CUREs) Initiative

Professor Jeremy Sanford launches new approach to increase undergraduate research experience Molecular Biologist Jeremy Sanford wants to expand opportunities for students to engage in meaningful, hands-on research projects at UC Santa Cruz. To overcome the limited number of student-researcher positions, Sanford is bringing his research into the laboratory classroom, where undergraduates can contribute. Sanford’s Curricular … Continue reading Guest Article: UC Santa Cruz MCD Biology launches Curricular Undergraduate Research Experiences (CUREs) Initiative

FAST, Fellow and CARB-X Updates January 2018

    FAST & Fellows Round-Up Inflammatix (FAST Fall 2017), a molecular diagnostics company that is developing rapid tests that read the immune system to improve disease diagnosis, announces appointment of Oliver Liesenfeld, M.D., former CMO of Roche Molecular Diagnostics, as Chief Medical Officer Read More LogicInk (FAST Spring 2017) is planning on launching its … Continue reading FAST, Fellow and CARB-X Updates January 2018

President’s Corner – 2017 Year in Review

By: Sara Radcliffe CLSA President & CEO December 21, 2017    The California Life Sciences Association (CLSA), along with the California Life Sciences Institute (CLSI), would like to thank everyone – members, board members, national organization partners, strategic partners, academic partners and the California life sciences community – for your membership, support and participation throughout the … Continue reading President’s Corner – 2017 Year in Review

Congress Passes Tax Reform Legislation, Protecting Critical Orphan, R&D Tax Credits

On Dec. 20, Congress passed a sweeping overhaul of the tax code in the form of H.R. 1, the Tax Cuts and Jobs Act. While CLSA did not take a position on the overall legislation, we did work in close collaboration and coordination with BIO and our CLSA member companies to ensure that the Orphan Drug Tax Credit – a meaningful incentive for investment in rare disease therapy innovation – was preserved in the final bill passed by Congress.